HCV - Liver / Kidney Transplantation
Metabolic Syndrome Is a Risk after Liver Transplantation, Leading to Poor Outcomes 1-15-2010 African Americans with Hepatitis C Have Worse Outcomes than White Patients after Liver Transplantation 12/15/09 Hepatitis C Patients Can Have Good Outcomes after Transplants Using HBV+/HCV+ Liver Grafts, but Donor Status May Affect HCV Recurrence 11/20/09 FDA Alert Warns of Elevated Risk of Death in Liver Transplant Recipients Who Switch to Rapamune (Sirolimus) 6/16/09 Kidney Disease in Patients with Chronic Hepatitis C 9/23/08 Older Donor Liver Grafts May Be Suitable for Chronic Hepatitis C Patients Requiring Transplantation 9/05/08 Selected Hepatitis C Patients with Decompensated Cirrhosis Can Benefit from Interferon-based Therapy prior to Liver Transplantation 6/10/08 Marijuana Use Sparks Liver Transplant Controversy 6/06/08 FibroScan Liver Stiffness Measurement Distinguishes Fast and Slow Fibrosis Patterns after Liver Transplantation 5/16/08
Cirrhosis Fibrosis Hepatocellular Carcinoma Liver Transplantation Liver Biopsy Steatosis Anemia Chilren / Infants / Women Drug Abuse Experimental Treatments FAQs About Hepatitis C Genotypes Insulin Resistance / Diabetes Sustained Viral Response (SVR) Tests for HCV Vaccines for HCV
